Franklin Resources Inc Heron Therapeutics, Inc. Transaction History

Franklin Resources Inc

  • $346 Billion
  • Q3 2024

A detailed history of Franklin Resources Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 23,026 shares of HRTX stock, worth $27,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,026
Previous 6,327,742 99.64%
Holding current value
$27,400
Previous $22.1 Million 99.8%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1.73 - $3.67 $10.9 Million - $23.1 Million
-6,304,716 Reduced 99.64%
23,026 $45,000
Q2 2024

Aug 14, 2024
SELL
$2.32 - $3.86 $108,673 - $180,810
-46,842 Reduced 0.73%
6,327,742 $22.1 Million
Q1 2024

May 13, 2024
SELL
$1.71 - $3.06 $51,660 - $92,445
-30,211 Reduced 0.47%
6,374,584 $17.7 Million
Q4 2023

Feb 09, 2024
SELL
$0.54 - $1.82 $298,790 - $1.01 Million
-553,315 Reduced 7.95%
6,404,795 $10.9 Million
Q3 2023

Nov 13, 2023
SELL
$0.97 - $1.8 $484,943 - $899,895
-499,942 Reduced 6.7%
6,958,110 $7.17 Million
Q2 2023

Aug 11, 2023
SELL
$1.11 - $2.88 $4.9 Million - $12.7 Million
-4,412,044 Reduced 37.17%
7,458,052 $8.65 Million
Q1 2023

May 12, 2023
BUY
$1.51 - $3.25 $3,497 - $7,527
2,316 Added 0.02%
11,870,096 $17.9 Million
Q4 2022

Feb 10, 2023
SELL
$2.25 - $4.67 $34,645 - $71,908
-15,398 Reduced 0.13%
11,867,780 $29.7 Million
Q3 2022

Nov 14, 2022
BUY
$2.66 - $5.37 $137,399 - $277,381
51,654 Added 0.44%
11,883,178 $50.1 Million
Q2 2022

Aug 11, 2022
SELL
$2.3 - $6.29 $108,219 - $295,957
-47,052 Reduced 0.4%
11,831,524 $33 Million
Q1 2022

May 13, 2022
SELL
$4.63 - $9.94 $411,556 - $883,556
-88,889 Reduced 0.74%
11,878,576 $67.9 Million
Q4 2021

Feb 11, 2022
SELL
$8.35 - $12.6 $108,524 - $163,762
-12,997 Reduced 0.11%
11,967,465 $109 Million
Q3 2021

Nov 12, 2021
SELL
$10.13 - $15.0 $13.1 Million - $19.3 Million
-1,288,258 Reduced 9.71%
11,980,462 $128 Million
Q2 2021

Aug 13, 2021
BUY
$13.27 - $18.48 $8.23 Million - $11.5 Million
619,826 Added 4.9%
13,268,720 $206 Million
Q1 2021

May 13, 2021
SELL
$14.49 - $20.72 $576,817 - $824,821
-39,808 Reduced 0.31%
12,648,894 $205 Million
Q4 2020

Feb 10, 2021
SELL
$14.61 - $22.14 $2.86 Million - $4.33 Million
-195,662 Reduced 1.52%
12,688,702 $269 Million
Q3 2020

Nov 12, 2020
BUY
$13.67 - $17.77 $4.36 Million - $5.67 Million
319,056 Added 2.54%
12,884,364 $191 Million
Q2 2020

Aug 13, 2020
SELL
$10.89 - $21.47 $1.93 Million - $3.8 Million
-176,963 Reduced 1.39%
12,565,308 $216 Million
Q1 2020

May 13, 2020
BUY
$10.23 - $24.56 $3.9 Million - $9.35 Million
380,860 Added 3.08%
12,742,271 $150 Million
Q4 2019

Feb 12, 2020
BUY
$17.42 - $26.61 $35.3 Million - $53.9 Million
2,026,380 Added 19.61%
12,361,411 $290 Million
Q3 2019

Nov 14, 2019
BUY
$16.36 - $21.39 $16.5 Million - $21.6 Million
1,009,504 Added 10.83%
10,335,031 $191 Million
Q2 2019

Aug 14, 2019
BUY
$16.93 - $26.22 $12.6 Million - $19.6 Million
746,650 Added 8.7%
9,325,527 $173 Million
Q1 2019

May 14, 2019
BUY
$23.15 - $28.34 $3.65 Million - $4.47 Million
157,586 Added 1.87%
8,578,877 $210 Million
Q4 2018

Feb 12, 2019
BUY
$22.03 - $32.01 $56.5 Million - $82 Million
2,563,015 Added 43.75%
8,421,291 $218 Million
Q3 2018

Nov 13, 2018
SELL
$30.0 - $40.85 $2.66 Million - $3.62 Million
-88,723 Reduced 1.49%
5,858,276 $185 Million
Q2 2018

Aug 14, 2018
SELL
$26.4 - $42.0 $28.9 Million - $46 Million
-1,095,894 Reduced 15.56%
5,946,999 $231 Million
Q1 2018

May 10, 2018
SELL
$18.43 - $28.8 $21.2 Million - $33.2 Million
-1,152,810 Reduced 14.07%
7,042,893 $194 Million
Q4 2017

Feb 14, 2018
SELL
$14.8 - $18.85 $3.37 Million - $4.29 Million
-227,474 Reduced 2.7%
8,195,703 $148 Million
Q3 2017

Nov 13, 2017
BUY
$14.65 - $16.85 $123 Million - $142 Million
8,423,177
8,423,177 $136 Million

Others Institutions Holding HRTX

# of Institutions
181
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $141M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email